Paula B. van Hennik

1.2k total citations
35 papers, 935 citations indexed

About

Paula B. van Hennik is a scholar working on Hematology, Molecular Biology and Immunology. According to data from OpenAlex, Paula B. van Hennik has authored 35 papers receiving a total of 935 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 13 papers in Molecular Biology and 11 papers in Immunology. Recurrent topics in Paula B. van Hennik's work include Hematopoietic Stem Cell Transplantation (10 papers), Mesenchymal stem cell research (6 papers) and Economic and Financial Impacts of Cancer (6 papers). Paula B. van Hennik is often cited by papers focused on Hematopoietic Stem Cell Transplantation (10 papers), Mesenchymal stem cell research (6 papers) and Economic and Financial Impacts of Cancer (6 papers). Paula B. van Hennik collaborates with scholars based in Netherlands, France and Sweden. Paula B. van Hennik's co-authors include Rob E. Ploemacher, Peter L. Hordijk, Carlijn Voermans, Albertus W. Wognum, Gerard Wagemaker, Monique M.A. Verstegen, Sacha B. Geutskens, C. Ellen van der Schoot, Ana Limón and Jean Paul ten Klooster and has published in prestigious journals such as Journal of Biological Chemistry, Blood and The Journal of Immunology.

In The Last Decade

Paula B. van Hennik

33 papers receiving 917 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paula B. van Hennik Netherlands	18	426	330	243	200	167	35	935
R Kay Canada	8	366 0.9×	373 1.1×	378 1.6×	232 1.2×	200 1.2×	10	994
R Schirò Italy	20	351 0.8×	558 1.7×	255 1.0×	324 1.6×	318 1.9×	35	1.2k
Marie-Laure Arcangeli France	18	836 2.0×	310 0.9×	491 2.0×	292 1.5×	107 0.6×	29	1.5k
Alexis Dumortier Switzerland	8	549 1.3×	297 0.9×	318 1.3×	146 0.7×	105 0.6×	8	1.0k
Gem S. Burgess United States	6	411 1.0×	300 0.9×	372 1.5×	144 0.7×	146 0.9×	6	959
Frederick Racke United States	20	747 1.8×	708 2.1×	388 1.6×	220 1.1×	310 1.9×	44	1.7k
Takahiro Ueda Japan	17	621 1.5×	406 1.2×	216 0.9×	175 0.9×	224 1.3×	51	1.2k
Friedrich W. Cremer Germany	19	560 1.3×	618 1.9×	167 0.7×	408 2.0×	158 0.9×	35	1.1k
Matthew P. McCormack Australia	18	642 1.5×	360 1.1×	315 1.3×	319 1.6×	107 0.6×	38	1.2k
Angelika M. Dräger Netherlands	13	205 0.5×	323 1.0×	261 1.1×	178 0.9×	125 0.7×	22	784

Countries citing papers authored by Paula B. van Hennik

Since Specialization

Citations

This map shows the geographic impact of Paula B. van Hennik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paula B. van Hennik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paula B. van Hennik more than expected).

Fields of papers citing papers by Paula B. van Hennik

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paula B. van Hennik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paula B. van Hennik. The network helps show where Paula B. van Hennik may publish in the future.

Co-authorship network of co-authors of Paula B. van Hennik

This figure shows the co-authorship network connecting the top 25 collaborators of Paula B. van Hennik. A scholar is included among the top collaborators of Paula B. van Hennik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paula B. van Hennik. Paula B. van Hennik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hoekman, Jarno, et al.. (2024). Factors affecting the feasibility of post-authorisation RCTs for conditionally authorised anticancer medicines: a multistakeholder perspective from a qualitative focus group study. BMJ Open. 14(11). e084483–e084483.

Hennik, Paula B. van, et al.. (2023). Single-arm trials supporting the approval of anticancer medicinal products in the European Union: contextualization of trial results and observed clinical benefit. ESMO Open. 8(2). 101209–101209. 8 indexed citations

Hennik, Paula B. van, et al.. (2022). A Comparison of Post-marketing Measures Imposed by Regulatory Agencies to Confirm the Tissue-Agnostic Approach. Frontiers in Medicine. 9. 893400–893400. 4 indexed citations

Delgado, Julio, Filip Josephson, Jorge Camarero, et al.. (2021). EMA Review of Acalabrutinib for the Treatment of Adult Patients with Chronic Lymphocytic Leukemia. The Oncologist. 26(3). 242–249. 8 indexed citations

Karres, Dominik, Paula B. van Hennik, Sabine M. J. M. Straus, et al.. (2020). EMA Recommendation for the Pediatric Indications of Plerixafor (Mozobil) to Enhance Mobilization of Hematopoietic Stem Cells for Collection and Subsequent Autologous Transplantation in Children with Lymphoma or Malignant Solid Tumors. The Oncologist. 25(6). e976–e981. 19 indexed citations

Camarero, Jorge, Paula B. van Hennik, B. Bolstad, et al.. (2020). European Medicines Agency extension of indication to include the combination immunotherapy cancer drug treatment with nivolumab (Opdivo) and ipilimumab (Yervoy) for adults with intermediate/poor-risk advanced renal cell carcinoma. ESMO Open. 5(6). e000798–e000798. 5 indexed citations

Moscetti, Luca, Paula B. van Hennik, B. Bolstad, et al.. (2020). Combinations in the first-line treatment of patients with advanced/metastatic renal cell cancer: regulatory aspects. ESMO Open. 5(4). e000856–e000856. 1 indexed citations

Tzogani, Kyriaki, Paula B. van Hennik, Jan Sjöberg, et al.. (2017). EMA Review of Panobinostat (Farydak) for the Treatment of Adult Patients with Relapsed and/or Refractory Multiple Myeloma. The Oncologist. 23(5). 631–636. 31 indexed citations

Hennik, Paula B. van, et al.. (2013). Nucleophosmin1 Is a Negative Regulator of the Small GTPase Rac1. PLoS ONE. 8(7). e68477–e68477. 8 indexed citations

10.

Klamer, Sofieke, Carlijn Kuijk, Peter L. Hordijk, et al.. (2013). BIGH3 modulates adhesion and migration of hematopoietic stem and progenitor cells. Cell Adhesion & Migration. 7(5). 434–449. 23 indexed citations

11.

Geutskens, Sacha B., et al.. (2012). Control of human hematopoietic stem/progenitor cell migration by the extracellular matrix protein Slit3. Laboratory Investigation. 92(8). 1129–1139. 26 indexed citations

12.

Voermans, Carlijn, Karel A. van Dort, Neeltje A. Kootstra, et al.. (2012). Regulation of CXCR4 conformation by the small GTPase Rac1: implications for HIV infection. Blood. 119(9). 2024–2032. 19 indexed citations

13.

Erpelinck-Verschueren, Claudia, Gorica Nikoloski, Bert A. van der Reijden, et al.. (2005). ID1 and ID2 are retinoic acid responsive genes and induce a G0/G1 accumulation in acute promyelocytic leukemia cells. Leukemia. 19(5). 799–805. 35 indexed citations

14.

Hennik, Paula B. van, et al.. (2004). Rac1 Mediates Collapse of Microvilli on Chemokine-Activated T Lymphocytes. The Journal of Immunology. 173(8). 4985–4993. 77 indexed citations

15.

Hennik, Paula B. van, Jean Paul ten Klooster, Carlijn Voermans, et al.. (2003). The C-terminal Domain of Rac1 Contains Two Motifs That Control Targeting and Signaling Specificity. Journal of Biological Chemistry. 278(40). 39166–39175. 90 indexed citations

16.

Hennik, Paula B. van, Elgin G.R. Lichtenauer-Kaligis, Leo J. Hofland, et al.. (2002). Somatostatin is a selective chemoattractant for primitive (CD34+) hematopoietic progenitor cells. Experimental Hematology. 30(2). 116–125. 37 indexed citations

17.

Voermans, Carlijn, Paula B. van Hennik, & C. Ellen van der Schoot. (2001). Homing of Human Hematopoietic Stem and Progenitor Cells: New Insights, New Challenges?. Journal of Hematotherapy & Stem Cell Research. 10(6). 725–738. 38 indexed citations

18.

Hennik, Paula B. van, et al.. (1999). Counterflow centrifugation allows addition of appropriate numbers of T cells to allogeneic marrow and blood stem cell grafts to prevent severe GVHD without substantial loss of mature and immature progenitor cells. Bone Marrow Transplantation. 23(10). 1061–1070. 6 indexed citations

19.

Hennik, Paula B. van, Monique M.A. Verstegen, Marti F.A. Bierhuizen, et al.. (1998). Highly Efficient Transduction of the Green Fluorescent Protein Gene in Human Umbilical Cord Blood Stem Cells Capable of Cobblestone Formation in Long-Term Cultures and Multilineage Engraftment of Immunodeficient Mice. Blood. 92(11). 4013–4022. 102 indexed citations

20.

Kwekkeboom, Jaap, et al.. (1997). Separation of G‐CSF‐mobilized PBSC transplants by counterflow centrifugal elutriation: modest enrichment of CD34⁺ cells but no loss of primitive haemopoietic progenitors. British Journal of Haematology. 99(1). 47–55. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact